Tag: addiction treatment

  • Opinion: The Opioid Crisis + COVID-19 = The Perfect Storm

    How can the addiction treatment community continue to assist people who are now being left even more isolated and desperate?

    Addiction – a chronic relapsing brain disorder, and a disease that gets deeply personal. It gets low-down and dirty, too.

    If you’re not an addict yourself, you surely know someone who is.

    You know someone abusing their opioid prescriptions, not because it’s a barrier to their pain, but because it’s a potent way to make them feel happier. You know someone whose alcohol consumption is dangerously high and verging on alcoholic – if they’re not already there, of course. Your kids will certainly know someone who abuses recreational drugs like they were going out of fashion. They’ll also know other students who swallow ADHD prescription tablets (as a study aid) because it makes them get their grades, and keeps their parents, people like you, happy.

    Among the people who are in your extended family, among your circle of friends, or someone within your workplace – at the very least, one, probably several more, will be a secret drug addict or an alcoholic. At the very least.

    It doesn’t discriminate. It certainly doesn’t care where you live either, just like most other diseases, and now this new coronavirusCOVID-19.

    Arizona & The Opioid Crisis

    Over the last 3 years, in Arizona alone, there have been more than 5,000 opioid-related deaths. Add to that the 40,000-plus opioid overdoses that have taken place during the same period, and you realize that COVID-19 has never been the only serious health issue the state continues to face, or the rest of the U.S., for that matter.

    In our “new reality” of social distancing and masks, more than 2 people every single day die from an opioid overdose in Arizona. Nearly half of those are aged 25-44 years old – in their prime, you might say.

    Opioids are not the only addictive group of substances that is costing young Arizonan lives right now either.

    From the abuse of “study aid” drugs, like Adderall and other ADHD medications, to the “party drugs,” like cocaine and ecstacy, and so to opioid prescription meds, and, if circumstances allow, a slow and deadly progression to heroin – addiction is damaging lives, if not ending them way too soon.

    These drugs did so before anyone had ever heard of COVID-19, and they’ll continue to do so after, or even if the world ultimately finds another drug – the elusive coronavirus vaccine – it is hoping for.

    Opioids + COVID-19 = The Perfect Storm

    We now live in this time of coronavirus. With the ongoing opioid epidemic, the question arises:

    How can the addiction treatment community continue to assist people who are now being left even more isolated and desperate, still with their chronic desire to get as high as they can, or drunker than yesterday?

    Furthermore, coronavirus has raised questions itself about the ongoing mental health needs of our population as a whole, and drug addicts and alcoholics continue to feature heavily in any statistics you offer up about those in the U.S. living with a mental health disorder.

    In fact, around half of those with a substance use disorder (SUD) or an alcohol use disorder (AUD) – the medical terminology for addiction – are simultaneously living with their own mental health disorder, such as major depression, severe anxiety or even a trauma-related disorder like PTSD.

    How are these predominantly socially-disadvantaged people able to receive the treatment they really need when they have been directed to isolate and socially distance themselves even further?

    This is why I believe the conditions for a “perfect storm” of widespread deteriorating mental health and self-medication through continued substance abuse are here now, with overdoses and fatalities rising across the addiction spectrum.

    There will be many drug or alcohol abusers living in Arizona who will be lost to us, and the majority will be young people in the age group of 25-44 mentioned previously, left isolated and unnoticed by an over-occupied medical community.

    The U.S. opioid epidemic plus the global coronavirus pandemic.

    A deceitfully isolating disorder in a time of generalized social isolation. For some, there will be no safe harbor from this, and it will wash them away from the lives of their families and friends without any chance of rescue whatsoever. The perfect storm – our perfect storm.

    Today, the truth is that successful addiction recovery has become exponentially more difficult. Apart from ongoing isolation to contend with, there exists an unfounded but very real distrust of medical facilities per se, and a real personal problem in maintaining good physical and mental health practices, eg. through nutrition and physical activity.

    Innovation: The Ideal Recovery Answer for Isolated Substance Addicts?

    Digital technology has advanced far further than its creators and financial promoters ever envisaged – or has it? We have become a society where it doesn’t matter where you are in the world, you’re always close by to loved ones you wish to talk to, friends you want to have a laugh with, and colleagues you need to share information with.

    Communication anywhere with anyone is as simple as the proverbial ABC.

    However, if you think that innovation and digital technology – sitting in front of your laptop or tablet, in other words – can provide the answers to the questions raised earlier about the timely provision of professional addiction or mental health treatment to those that need it, then you’re wrong. If only it were all that simple and straightforward.

    Online meetings of 12-Step organizations, like Alcoholics Anonymous, Narcotics Anonymous, and others, have been available for many years. However, all of these support organizations realize that an online or virtual 12-Step meeting is not the real thing. They are a temporary substitute and no more.

    In fact, they are a poor substitute when compared to the face-to-face and hands-on meetings that continue to be held successfully all over the nation and all year round.

    The various “sober aware” and “sober curious” communities that are present online do not provide a realistic treatment option to any substance addicts whatsoever, whether their SUD or AUD has been clinically diagnosed or not. Furthermore, the current crop of online addiction treatment and recovery programs available are currently statistically unproven in terms of successful outcomes, and with no official accreditation.

    That said, there is limited evidence that “telemental health care” does have several benefits in terms of more timely interventions in those with mental illness generally, particularly when these people are located in isolated communities.

    I honestly wouldn’t know, as there is no official patient outcome data for these services. In fact, by the time that data is able to be impartially and officially collected, these groups and so-called programs may have already lost their internet presence.

    Online “help” (you honestly couldn’t call it an actual treatment) with addiction is severely limited and nowhere near approaching the answer. Here’s exactly why…

    Substance addiction is an utterly isolating disorder. It can obliterate close family bonds, destroy what keeps us close together as friends, and will happily rampage unabated through any social life you may still hold onto, accepting no prisoners. Bleak isolation like you’ve never known before.

    Corona has little on addiction.

    Addiction is the catalyst behind premature death, the end of families and their marriages, long-term unemployment, and endless legal issues. It costs financially too – countless billions of dollars every year are lost to this disorder, over double that of any other neurological disease.

    Let me be absolutely clear and concise – there exists no replacement whatsoever for your hand held by another when lying in an intensive care bed, scared you’ll become just another coronavirus statistic, and there exists no replacement for the smiles, warmth, and openness of fellow recovering drug addicts meeting in a daily support group, especially on those days when you came so close, so very close, to using or drinking again.

    There’s little difference between the two either.

    The online addiction treatment industry is still in its childhood. It truly is an industry too, as you’ll only buy the brand and the product; you’ll never actually meet those telling you how to best change your life.

    At present, it falls woefully short.

    Really, what would you prefer? A mask-wearing addiction professional, clinically qualified to assist with your detox, your medication if needed, and your psychological needs, located in an accredited treatment facility (formally certified as being coronavirus-free), among peers, fellow addicts, and trained medical staff?

    Or a video image on a computer screen of someone you will never meet, who is telling you to do things you’ve never done before? At least, successfully?

    As society moves towards a more home-orientated existence, with WFH (working from home) the new norm, consider this:

    Would a specialized medical professional treating your disease ask you to consider “getting better from home,” as an alternative to the hospital?

    All we can hope for – the best that we can hope for – is that coronavirus soon leaves the state lines of Arizona, and that can continue all of our recoveries as successfully as before. Until then, the advice is simple – take the best help you can from wherever you can get it. Sadly, you are yet to find it on a computer screen.

    One last thought before I sign off…

    Protective masks may well become standard attire in our unknown future. So why, oh why, can they not make these transparent? Just take a moment… We’d be able to see each other – our friends, our colleagues, even complete strangers in the street – smile again.

    View the original article at thefix.com

  • Can A Brain Chip Curb Opioid Addiction?

    Can A Brain Chip Curb Opioid Addiction?

    The first participant to receive the implant in the trial has battled treatment-resistant opioid and benzo addiction for over a decade. 

    There’s been a number of technological advances in addiction medicine over the past decade. Recovery-based apps, neurofeedback therapy and even virtual reality have ushered in a slew of treatment options for addiction.

    Now, researchers at the West Virginia University Rockefeller Neuroscience Institute and West Virginia University Medicine are conducting the first US clinical trial for a deep brain stimulation device that will target areas in the brain linked to addiction and self-control. 

    According to TechCrunch, the deep brain stimulation device will “monitor cravings in real time,” giving researchers critical insight into how addiction works in the brain. 

    West Virginia In Crisis

    The West Virginia-based organizations announced the launch of the clinical trial on Tuesday, November 5. The state, which leads the country in fatal overdose deaths, has been hit particularly hard by the opioid epidemic. 

    “Our team at the RNI is working hard to find solutions to help those affected by addiction,” Dr. Ali Rezai of the Rockefeller Neuroscience Institute explained. “Addiction is a brain disease involving the reward centers in the brain, and we need to explore new technologies, such as the use of DBS, to help those severely impacted by opioid use disorder.” 

    The trial is a small one consisting of four participants with treatment-resistant opioid addiction. Prior to this trial, the DBS device had only been tested on mice with promising results.

    Deep brain stimulation is used to treat chronic pain, Parkinson’s disease, treatment-resistant depression and obseessive compulsive disorder. According to the American Association of Neurological Surgeons, (AANS) around 35,000 people have DBS implants. 

    “Despite our best efforts using current, evidence-based treatment modalities, there exist a number of patients who simply don’t respond. Some of these patients remain at very high risk for ongoing catastrophic health problems and even death. DBS could prove to be a valuable tool in our fight to keep people alive and well,” said Dr. James Berry.

    The first patient to receive the Medtronic DBS device in the trial was a 33-year-old man who has been battling treatment-resistant opioid and benzo addiction for over a decade. 

    View the original article at thefix.com

  • Lena Dunham Talks About Shame After Rehab

    Lena Dunham Talks About Shame After Rehab

    “When I was dropped at rehab, I thought it was the end of my life,” Dunham said.

    Actress Lena Dunham, who celebrated one year of sobriety in April, spoke candidly this week about her time in treatment and how she experienced shame even after she got sober. 

    I Thought It Was The End Of My Life

    Dunham was speaking at a fundraiser for Friendly House, which provides treatment to women who need it. 

    “I’m here because getting sober changed my life and I’m really, really passionate about recovery and sober living being available for everyone no matter their income bracket, especially for women who are so often put in danger when they are new to sobriety,” Dunham said, according to People

    At the event, Dunham gave a speech about her recovery experiences.

    “When I was dropped at rehab, I thought it was the end of my life,” Dunham said. “Seemingly overnight I had lost almost all of what I held dear. My relationships, my body and my career were in relative shambles from decisions I had made and things that had happened. Well, I was under the influence of pills that I thought dulled my pain, but actually created it. I kept repeating the phrase I just don’t see a place for myself in the world anymore. And that wasn’t suicidal ideation. Exactly. I had simply edged myself out of the picture. Like I was a Polaroid. That wouldn’t develop.”

    She said that she could feel the pain from all the other patients, and that made her willing to open up about her own suffering.  

    “I was such an open nerve that on my first day of group therapy when I was asked to share a little bit about why I was there, I told my seemingly endless tale of woe,” she said. “You know, the one, just the one that justified and necessitated being numbed by medication. The patients. And the therapist simply looked at me and said, ‘shit.’”

    Her connections with that group eventually helped her get and stay sober. 

    “I allowed myself to be loved by a group of people in recovery who showed me that I was worth saving and worth loving no matter what metaphorical and like sometimes literal alleys I had wandered down,” she said. 

    Facing Addiction Stigma

    Still, Dunham said that she worried about being labeled after rehab, and dealt with a lot of shame. 

    “Not just the shame of facing decisions I didn’t like in my recent past, but the shame of this new title drug addict, couldn’t you call me something cooler? Like, like I dunno like Oxycontin expert? That’s close to being a doctor. But even as a chronic oversharer I lived in fear of anyone finding out this fact of my life. I went everywhere under a false name. I registered everywhere, not as myself. Were people still going to work with me, kiss me, hang out with me after midnight just shooting the shit and sometimes smoking a cigarette? Would everything I’ve ever done you’ve viewed through the lens of addiction?”

    Now, she says, she has learned to be herself in a happier and healthier way.  

    “I realized being me has hurt and sometimes it’s hurt so much that I couldn’t bear it. But being me is also a super power.”

    View the original article at thefix.com

  • Hospitals Sue Drug Companies, Seeking Opioid Settlement Money

    Hospitals Sue Drug Companies, Seeking Opioid Settlement Money

    These lawsuits are separate from those filed by thousands of American municipalities against many of the same companies.

    Hospitals are joining the fight in trying to squeeze settlement money from drug companies accused of fueling opioid abuse and overdose in the U.S.

    The High Cost Of Addiction Treatment

    Hospitals in Mississippi, Tennessee, Texas, Arizona, Florida, Kentucky and West Virginia are suing companies like Purdue Pharma, Johnson & Johnson and McKesson, a drug distributor, hoping to recoup the heavy cost of treating the opioid crisis.

    “The expense of treating overdose and opioid-addicted patients has skyrocketed, straining the resources of hospitals throughout our state,” said Lee Bond, chief executive officer of Singing River Health System in Mississippi, which is also suing.

    These lawsuits are separate from those filed by thousands of American municipalities against many of the same companies.

    Hospitals see the worst of the opioid crisis firsthand. People who overdose, or require treatment for serious illness like endocarditis, pneumonia and hepatitis, are often unable to pay for treatment.

    According to court filings cited by NPR, hospitals estimate that the cost of treating such patients amounts to an average of $107,000 per person. In just one year, providing treatment for opioid-related sickness has cost U.S. hospitals over $15 billion, according to 2012 statistics.

    “I can’t pay a thing. I don’t have a dime. So they do absorb all that cost,” said Traci Grimes, a woman from Nashville who was treated at Vanderbilt University Medical Center (which is not involved in any lawsuit) for near-fatal endocarditis, hepatitis A and C, and pneumonia.

    Hospital Lawsuits Could Open “New Can Of Worms”

    Health experts noted that hospitals may be reluctant to sue in order to protect sensitive information such as how they determine their prices for care, or their relationships with drug companies. This may garner “some unflattering attention” for some hospitals, a health analyst explained to NPR. It could potentially open “a whole new can of worms,” making it a safer choice to sit out on litigation.

    However, the downside of sitting out is that hospitals are not guaranteed to receive any of the settlement money won by municipalities, experts noted.

    Ohio Governor John Kasich and West Virginia University President Gordon Gee want more hospitals to join as plaintiffs.

    “Hospitals are directly bearing the brunt of this crisis,” it says on the website for their organization, Citizens for Effective Opioid Treatment. “U.S. hospitals provide billions of dollars annually in reimbursed care directly related to the opioid crisis.”

    Gee told NPR, “There’s always safety in mass.”

    View the original article at thefix.com

  • Four States Propose $48 Billion Settlement In Global Opioid Lawsuit

    Four States Propose $48 Billion Settlement In Global Opioid Lawsuit

    The $48 billion offer is still a far cry from the estimated $504 billion in damages caused to the country in 2015 alone.

    The attorneys general of four U.S. states have proposed a $48 billion settlement between some of the world’s biggest drug companies and states, tribes and nearly 3,000 cities and counties across the nation at what could be the peak of the opioid epidemic. 

    The offer comes shortly after what would have been the first federal opioid trial was averted by a $250 million settlement between Cardinal Health, McKesson, and AmerisourceBergen and two counties in Ohio.

    The global settlement deal was proposed by two Democratic and two Republican attorneys general of North Carolina, Pennsylvania, Texas, and Tennessee. According to NBC News, the foursome has not yet announced whether any other states are on board with their plan.

    Is $48 Billion Enough?

    However, a lawyer representing the cities and counties involved in the global suit, Paul Hanly, believes that this number is not high enough for his clients. It’s likely that negotiations will continue for another three to six months, he said.

    “This is the most complex negotiation in the history of litigation,” said Hanley.

    Last week, Hanley’s clients rejected an offer of $18 billion over the course of 18 years after it was found that New York City would have only received as little as $5 million per year from the deal, a small fraction of the $500 million per year it has spent to combat the opioid crisis. The same issue applied to other cities.

    The $48 billion offer is still a far cry from the estimated $504 billion in damages caused to the country in just the year 2015.

    Funds Would Be Delivered Over 10-Year Period

    The settlement would also be split between cash payments and services and supplies. The deal proposed for the global case would offer over $22 billion in cash as well as $26 billion in treatment drugs and delivery services, all of which would be delivered over the course of 10 years. 

    In Ohio, drug distributors Cardinal Health, McKesson, and AmerisourceBergen paid $215 million to Summit and Cuyahoga counties, while generic opioid maker Teva Pharmaceutical paid $20 million in cash and provided $25 million worth of Suboxone, a common opioid addiction treatment drug. The cash payments will also go toward treatment efforts.

    “We are looking at using this money for treatment,” said Cuyahoga County prosecutor Michael C. O’Malley. “It’s about rehabilitation and getting people straight.”

    Meanwhile, Walgreens Boots Alliance, another defendant in the Ohio case, has not yet announced its settlement with the plaintiffs. Purdue Pharma, whose name is often evoked when it comes to the opioid crisis, was also a target of these lawsuits but filed for bankruptcy in September.

    All companies involved have denied the allegations that they’re responsible for the opioid epidemic, but the three who settled last week released a joint statement saying that the deal is “an important stepping stone to achieving a global resolution and delivering meaningful relief.”

    View the original article at thefix.com

  • Germany Doesn’t Have An Opioid Crisis. Here’s Why. 

    Germany Doesn’t Have An Opioid Crisis. Here’s Why. 

    One German doctor believes the country’s hesitance to prescribe opioids plays a major role in helping avert a crisis.

    With recent stories warning about addiction taking hold in India and Australia, it can seem like the opioid epidemic is much larger than North America. However, Germany has largely avoided the crisis, in part because of its approach to pain management and in part because when addiction does arise, it is treated more quickly and effectively. 

    While opioid prescription rates in the United States have been rising exponentially, they’ve only increased slightly in Germany, NBC News reported.

    Dr. Peter Raiser is the deputy managing director at the German Center for Addiction Issues. He said that healthcare providers in the country take a much more controlled approach to opioid pain pills. That’s kept prescription rates relatively stable, even while they skyrocketed in other Western countries. 

    Raiser said, “Among the most important reasons we do not face a similar opioid crisis seems to be a more responsible and restrained practice of prescription.”

    Doctors Need Special Permission To Prescribe Opioids

    A major difference is that opioids are not a first-line option for pain management in Germany, as they often are in the United States. Doctors need special permission to prescribe opioids to a patient. In order to be granted that permission, they need to show that they’ve trial alternative treatments and medications, and that those have been unsuccessful. Then, patients need to be screened for addiction risk. 

    University of Hamburg psychiatrist Dr. Dieter Naber said those precautions lower the number of opioid prescriptions that are written. 

    He said, “Here in Germany, they prescribe opiates if all the other drugs don’t work. It’s much, much, much more difficult.”

    Affordable Healthcare Means More Doctor Visits

    In part because opioids are less prevalent, opioid use disorder is also less common in Germany. About 0.2% of Germans live with opioid use disorder, compared with 0.6% of Americans. 

    One reason may be because Germans are more likely to keep in touch with the doctors that prescribed their opioids, since healthcare is cheaper than it is in the United States. Since they’re seeing patients more frequently, doctors are better able to spot signs of opioid abuse. 

    When Germans do become addicted to opioids, they’re much less likely to die than their American counterparts with substance use disorder, since treatment is more affordable and widely available.

    Naber explained, “Money regarding treatment is really not an issue here.” 

    In 2016, 198 Americans per one million died of drug overdoses, compared to just 21 Germans per million

    Harm Reduction In Action

    For people who are not willing to go into treatment, Germany has harm reduction programs, including more than 20 safe injection sites. The United States has none (although some cities are considering plans). 

    Dr. Andres Roman-Urrestarazu, a University of Cambridge researcher, said the German approach recognizes addiction as a more complicated and nuanced problem that requires a variety of solutions. 

    “We know harm reduction works in terms of dealing with the problem of mortality,” he said. 

    View the original article at thefix.com

  • Google Honors Addiction Treatment Pioneer Dr. Herbert D. Kleber

    Google Honors Addiction Treatment Pioneer Dr. Herbert D. Kleber

    Kleber, who died last year, was honored with a very special Google Doodle on Tuesday. 

    If you used the Google search engine on Tuesday, you would have seen a Google Doodle honoring Dr. Herbert D. Kleber, who spent more than 50 years pioneering addiction treatment, including the use of medication-assisted treatment for substance use disorder. 

    Kleber, who died last year at the age of 84, began his medical career in 1964, with an assignment to the Public Health Service Prison Hospital at Lexington, Kentucky. There, he was saw firsthand how people with substance use disorder were treated, according to CNN

    “Most people didn’t get therapy. Most people had work therapy,” Kleber said in an oral history for Columbia University, where he later worked. “They’d be assigned to the kitchen. They’d be assigned to the farm. They’d be assigned to the woodshop, which made furniture. They’d be assigned to the laundry, whatever, whatever.”

    A Thought Leader Who Knew Early On That Treating Addiction As A Moral Failing Was Wrong

    At the time, most saw addiction as a moral failing, but Kleber could see that it was actually the treatment system that was failing patients. 

    “There was about a 90% relapse rate within the first 90 days,” he said. 

    Two years later, Kleber returned to Yale.  

    “The last thing in the world I wanted to do was to treat addiction,” he said. “But once you had been at Lexington, you were a marked man. That is, people sought you out who thought you might know something about treating addiction.”

    He realized that studying addiction might be his “fate,” and received funding from the National Institutes of Health to devise a treatment program that would help people stay sober. Kleber integrated methadone treatment with a community-based behavioral model. Over the years he tried many medications for treating addiction to a variety of substances. 

    He Oversaw The National Policy Center on Addiction and Substance Abuse With His Wife

    Kleber became the Deputy Director for Demand Reduction at the Office of National Drug Control Policy in 1989, despite the fact that some people opposed his appointment. He was seen as “soft on drugs” because he favored medication-assisted treatment. After that, Kleber worked at Columbia University, overseeing the National Policy Center on Addiction and Substance Abuse with his wife, Marian Fischman.

    Kleber said in his oral history, which was recorded in 2015, that there’s still strife between 12-step and medication-assisted treatment models, but he believed that would change as long-acting and non-addictive treatments for substance use disorder, like Vivitrol, became more widely available.

    “As those get perfected, you’re going to see important changes in how treatment is carried out,” he said. 

    Tuesday (Oct. 1) marked the 23rd anniversary of Kleber’s election to the National Academy of Medicine.

    View the original article at thefix.com

  • Metallica's James Hetfield Returns To Rehab

    Metallica's James Hetfield Returns To Rehab

    The 56-year-old frontman’s battle with addiction was chronicled in Metallica’s 2004 documentary Some Kind Of Monster.

    Right before a planned tour of Australia and New Zealand, Metallica has announced that the band’s frontman James Hetfield is making a return to rehab.

    As the band explained in a statement on September 27, “We are truly sorry to inform our fans and friend that we must postpone our upcoming tour of Australia and New Zealand. As most of you probably know, our brother James has been struggling with addiction on and off for many years. He has now, unfortunately, had to re-enter a treatment program to work on his recovery again.”

    The band continued that they “fully intend to make our way” down under “as soon as health and schedule permits… We appreciate your understanding and support for James and, as always, thank you for being a part of our Metallica family.”

    Peers, Fans Show Their Support

    Once the news hit, several musicians expressed their support for Hetfield, who first went into rehab in 2001. Former Guns N’ Roses drummer Matt Sorum tweeted, “Sending my best to James Hetfield of @Metallica. Take care of yourself my friend. You are a human being like everyone else that has real struggles. The disease of alcoholism doesn’t discriminate. You are very strong to take the steps needed to be healthy and happy. The rest can wait.”

    Jamey Jasta, lead singer of Hatebreed, revealed on Twitter that he “would not have given up drinking if it wasn’t for James and the example he set…I commend James for seeking help…I hope that all #Metallica fans affected by this understand that this is absolutely the best choice. Health is EVERYTHING. No tour or album or mountain of obligations is worth diving back into the abyss of booze & drugs.”

    James Discusses First Rehab Stint

    After he first got sober, Hetfield told Kerrang! “Going away to rehab taught me about priorities. I’ve been in Metallica since I was 19 years old, which can be a very unusual environment, and it’s very easy to find yourself not knowing how to live outside of that environment, which is what happened to me. I didn’t know anything about life… I didn’t know that I could live my life in a different way to how it was in the band, which was very excessive and very intense.”

    Hetfield called rehab “like college for your head. I really learned some things about myself in there. I was able to reframe my life and not look at everything with a negative connotation. That’s how I was raised. It was like a survival technique for me.”

    View the original article at thefix.com

  • Online Tool For Tracking Treatment Beds Unveiled In San Francisco

    Online Tool For Tracking Treatment Beds Unveiled In San Francisco

    The tool will go live on the SF Health Network website in November.

    A new online tool is scheduled to go live in November to help homeless San Franciscans find available treatment beds for substance use disorder or mental illness.

    Mayor London Breed unveiled the tool on Tuesday (Sept. 24), as part of her Heal Our City initiative.

    “When someone is experiencing homelessness, mental illness, and a substance use disorder, the last thing we should be doing is making it more complicated for them to get the care they need,” said Breed. “With this real-time data, we’ll be able to connect people more efficiently with available treatment beds, make better use of our existing resources, and identify opportunities for improvement in our existing system of care.”

    Going Live In November

    The tool will go live on the SF Health Network website in November. Anyone will have access to real-time information about the 350 short-term behavioral health treatment beds in San Francisco.

    “We want to make the best possible use of the substance-use and mental health treatment resources that San Francisco already provides, and to make data-driven decisions about where we need to add services,” said Dr. Anton Nigusse Bland, the city’s first director of mental health reform.

    However, not everyone was moved by the mayor’s announcement. “It’s mind boggling that our Department of Public Health still doesn’t know where its own beds are or who is in them,” said city supervisor Matt Haney, according to the SF Examiner. “This is a long overdue, though really minor, basic step towards a functional system.”

    Haney is a vocal advocate for reforming the city’s approach to mental health care, drugs, and its homeless population. He has been critical of the city’s lack of a “comprehensive citywide strategy” in tackling these issues.

    Drugs In The Tenderloin

    This year it was reported that more than half (56%) of those arrested or cited for selling drugs in SF in 2017-2018 were in the Tenderloin, a neighborhood which falls under Haney’s District 6.

    The problem is so dire that Haney introduced a city resolution that would declare drug abuse and overdose a public health crisis. He also sponsored legislation to establish a Street-Level Drug Dealing Task Force, which passed Tuesday (Sept. 24), to advise city officials on how to tackle its problem with drug dealing.

    This November, Haney is urging San Franciscans to vote in favor of Mental Health SF, a program that would guarantee treatment for mental illness and substance use disorder for every resident.

    “San Francisco has the opportunity to lead, to say, ‘This should be a right for everybody.’ We’re going to build a system around it,” Haney said in May.

    View the original article at thefix.com

  • All Adults Should Be Asked About Illicit Drug Use, Task Force Finds

    All Adults Should Be Asked About Illicit Drug Use, Task Force Finds

    According to the task force, 10% of American adults have used illegal drugs in the past month.

    All adult patients in the U.S. should be asked about their illicit drug use, according to recommendations released this week by the U.S. Preventive Services Task Force. 

    “Illicit drug use can have a devastating impact on individuals and families,” task force co-vice chair Karina Davidson said in a statement with the release of the recommendation, which is available here. “Clinicians can help by screening their adult patients and connecting people who use illicit drugs to the care they need to get better.”

    According to the task force, 10% of American adults have used illegal drugs in the past month. If doctors ask about this and know about their patients’ drug use, they will be better able to deliver care and connect their patients with evidence-based treatments for drug use and abuse.

    Dr. Gary LeRoy, president-elect of the American Academy of Family Physicians, told The Los Angeles Times that he has been screening patients for drug use for 10 years in his Dayton, Ohio practice.

    “All of us should be keenly aware that on average, one in 10 of our patients are doing drugs—whether we ask them or not—and we’re not going to cause someone to use illicit drugs because we ask the question,” he said. “When you create an atmosphere of trust where you have safe conversations, they appreciate that you ask.”

    LeRoy said that asking all patients about their drug use—of so-called street drugs and misuse of prescription medications—can help doctors get to know their patients better.

    “They say, ‘Oh, I had no idea I already had these people in my practice,’” he said. “When I started asking these questions and providing the service, they came out of the woodwork.”

    The task force considered recommending screenings for everyone in 2008, but opted not to. That has changed at least in part because there are now more proven ways to treat drug addiction, said UCLA internal medicine specialist and task force co-chair Dr. Carol Mangione.

    Treatment & Prevention

    Mangione said, “We don’t want to screen for something unless we know there’s an effective treatment. If you don’t have a treatment that’s effective for people who screen positive, you haven’t really helped.”

    Today, people who talk to their doctor about illicit drug use can be connected with help that is proven to be efficient.

    The recommendation only concerns adults ages 18 and older, but the task force said that doctors should consider asking teens about illicit drug use too.

    “We want to help prevent illicit drug use in teens, so we’re calling for more research on the benefits of screening,” Mangione said in a statement. “Clinicians should continue to use their professional judgement to determine what’s best for their teen patients.”

    View the original article at thefix.com